S.E.E.D. Planning Group »

Arcutis Biotherapeutics shares owned by S.E.E.D. Planning Group

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by S.E.E.D. Planning Group from 13F filings

Historical chart of S.E.E.D. Planning Group investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by S.E.E.D. Planning Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by S.E.E.D. Planning Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $245k 13k 18.85

More positions owned by S.E.E.D. Planning Group

Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Microsoft Corporation (MSFT)
Thermo Fisher Scientific (TMO)
Agilent Technologies Inc C ommon (A)
Meta Platforms Cl A (META)
Nextera Energy (NEE)
Valero Energy Corporation (VLO)
Linde SHS (LIN)
Automatic Data Processing (ADP)
Corteva (CTVA)
Lockheed Martin Corporation (LMT)
Enbridge (ENB)

View all positions for S.E.E.D. Planning Group

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Rubric Capital Management
Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Vanguard Group
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
Morgan Stanley
UBS Group
Geode Capital Management
Henderson Group
Franklin Resources
Pivotal bioVenture Partners Investment Advisor

View all funds holding Arcutis Biotherapeutics